Dyspareunia future or investigational therapies: Difference between revisions
| Line 7: | Line 7: | ||
==Future or investigational therapies== | ==Future or investigational therapies== | ||
More research must be done to suggest a strong genetic link with Genito-Pelvic Pain/Penetration Disorder (GPPPD).<ref>https://doi.org/10.18192/uojm.v7i2.2198</ref> | potential genetic predisposition to chronic inflammation among Vestibulodynia afflicted women. These genetic polymorphism leads to a reduced capacity to terminate and to an exaggerated inflammatory response.More research must be done to suggest a strong genetic link with Genito-Pelvic Pain/Penetration Disorder (GPPPD).<ref>https://doi.org/10.18192/uojm.v7i2.2198</ref> | ||
==References== | ==References== | ||
Revision as of 01:57, 21 September 2020
|
Dyspareunia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dyspareunia future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Dyspareunia future or investigational therapies |
|
Risk calculators and risk factors for Dyspareunia future or investigational therapies |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
More research must be done to suggest a strong genetic link with Genito-Pelvic Pain/Penetration Disorder (GPPPD).
Future or investigational therapies
potential genetic predisposition to chronic inflammation among Vestibulodynia afflicted women. These genetic polymorphism leads to a reduced capacity to terminate and to an exaggerated inflammatory response.More research must be done to suggest a strong genetic link with Genito-Pelvic Pain/Penetration Disorder (GPPPD).[1]